ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Anders Franco-Cereceda
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franco-Cereceda, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franco-Cereceda, A.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Coronary disease

Ann Thorac Surg 2006;81:2154
© 2006 The Society of Thoracic Surgeons

Original article: Cardiovascular

Invited commentary

Anders Franco-Cereceda, MD, PhD

Department of Thoracic Surgery, Karolinska University Hospital, Stockholm, 171 76 Sweden

(Email: andfra@mbox.ki.se).

The first 20% of the full text of this article appears below.

The use of the radial artery as a graft for coronary revascularization was already introduced in the 1970s, but shortly thereafter it was abandoned due to a high rate of graft failure. This was partly due to the inability to recognize radial artery spasm, but it was also due to lack of proper pharmacological tools to prevent this. Because it was . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.